Page last updated: 2024-08-22

tiletamine hydrochloride and Weight Reduction

tiletamine hydrochloride has been researched along with Weight Reduction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horiguchi, Y; Kanao, K; Kikuchi, E; Kuroda, K; Miyajima, A; Murai, M; Nakashima, J; Ohigashi, T; Umezawa, K	1
Finegold, M; Jorquera, R; Langlois, C; Shroads, AL; Stacpoole, PW; Tanguay, RM	1

Other Studies

2 other study(ies) available for tiletamine hydrochloride and Weight Reduction

Article	Year
Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15 Topics: Albumins; Animals; Antineoplastic Agents; Benzamides; Body Mass Index; Body Weight; Cachexia; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasm Transplantation; NF-kappa B; Prostatic Neoplasms; Time Factors; Triglycerides; Weight Loss	2005
Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1. Biochemical pharmacology, 2006, May-28, Volume: 71, Issue:11 Topics: Animals; Cyclohexanones; Dichloroacetic Acid; Female; Glutathione; Glutathione Disulfide; Hydrolases; Kidney; Liver; Male; Mice; Nitrobenzoates; Oxidative Stress; Tyrosine; Tyrosinemias; Weight Loss	2006

Article

Year

Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Aug-01, Volume: 11, Issue:15

Topics: Albumins; Animals; Antineoplastic Agents; Benzamides; Body Mass Index; Body Weight; Cachexia; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasm Transplantation; NF-kappa B; Prostatic Neoplasms; Time Factors; Triglycerides; Weight Loss

2005

Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.

Biochemical pharmacology, 2006, May-28, Volume: 71, Issue:11

Topics: Animals; Cyclohexanones; Dichloroacetic Acid; Female; Glutathione; Glutathione Disulfide; Hydrolases; Kidney; Liver; Male; Mice; Nitrobenzoates; Oxidative Stress; Tyrosine; Tyrosinemias; Weight Loss

2006